Thank you for the question.
I think what you're alluding to is the national strategic emergency stockpile, which we know had funding cut in the lead-up to the pandemic. Certainly there were challenges, I think, in administration. There was PPE that was expired. It's supposed to have some of these other medications that we would need for people who would get sick with a viral illness, like COVID, and it's supposed to have ventilators as well.
My hope, going forward, would be that this critical drug reserve, which presumably is the new name for the strategic stockpile, would be funded and would continue, and we would actually have ongoing analysis of international supply chains.
The challenge is obviously that if we keep some of these medications in stockpiles, they often expire. When I've talked to different organizations and industry experts as well, there have been suggestions that perhaps we could actually get factories overseas, or some of our factories here, to hold the precursors for the drugs or even stockpile that way, so that we have industry managing it. It might actually be that they are just better at doing that, so let government do what it does best.